Abstract
The authors report nine patients with systemic lupus erythematosus associated with anti-topoisomerase I antibodies (ELISA test) without features of systemic sclerosis. These antibodies were correlated with the disease activity and might be a marker of the severity of the closely related to difusse proliferative glomerulonephritis.
References
Gussin HAE, Ignat GP, Varga J, Teodorescu M (2001) Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 44:376–383
Mukai M, Sagawa A, Atsumi T et al (1993) Three cases of anti-Scl-70 (topoisomerase I) antibody associated with central nervous system lupus without renal disorder. J Rheumatol 20:1594–1597
Stojanov L, Satoh M, Dooley MA, Kuwana M, Jennette JC, Reeves WH (1995) Autoantibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of scleroderma. Lupus 4:314–317
Watanabe T, Tsuchida T, Kanda N, Tamaki K (1997) Avascular necrosis of bone in systemic lupus erythematosus : the predictive role of precipitating autoantibodies. Scand J Rheumatol 26:184–187
Al Attia HM, D'Souza MS (2003) Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma: two case reports. Clin Rheumatol 22:70–72
Ignat GP, Rat A-C, Sychra JJ, Vo J, Varga J, Teodorescu M (2003) Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies. J Rheumatol 30:1761–1769
Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology 42:276–279
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamidou, M.A., Audrain, M.A., Masseau, A. et al. Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis. Clin Rheumatol 25, 542–543 (2006). https://doi.org/10.1007/s10067-005-0061-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0061-9